Clinical trials sponsored by Chinese PLA General Hospital
12
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 2Phase 2 3Phase 4 1Not applicable 7
Conditions studied
Recruiting trials led by Chinese PLA General Hospital
- 7.0T Magnetic Resonance Imaging Study of Parkinson's Disease
- Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)
- Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
- Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU
- Comparative Study of Prognosis and QOL Between APD-RPM and CAPD
- Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy
- Hydration Guided by Remote Dielectric Sensing (ReDS) System for Preventing Acute Kidney Injury in Elderly Patients With Renal Insufficiency for Coronary Angiography and Intervention
- Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease
- Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy
- Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
- Study Safety and Efficacy of Deep Brain Stimulation (DBS) and Cervical Deep Lymphoid-venous Anastomosis (LVA) in Alzheimer's Disease
- Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer
Common questions
How many trials is Chinese PLA General Hospital recruiting for?
Chinese PLA General Hospital is the lead sponsor of 12 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.